{"disease":{"id":"diarrhea-predominant-irritable-bowel-syndrome","name":"diarrhea predominant irritable bowel syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02612649","title":"Special Drug Use Surveillance of Irribow in Female Patients","phase":"","overall_status":"COMPLETED","enrollment_count":793,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT06346847","title":"Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS","phase":"NA","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"A-Mansia Biotech S.A.","has_results":false},{"nct_id":"NCT03099785","title":"Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"Cosmo Technologies Ltd","has_results":false},{"nct_id":"NCT05687435","title":"Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Mei Han","has_results":false},{"nct_id":"NCT03977155","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Boston Pharmaceuticals","has_results":true},{"nct_id":"NCT07000383","title":"Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT05941650","title":"To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Universidad Autonoma de Chihuahua","has_results":false},{"nct_id":"NCT02728063","title":"Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"PiLeJe","has_results":false},{"nct_id":"NCT02358694","title":"Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Connecticut Children's Medical Center","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}